Analyst Consensus ?
ConsensusHold29 ratings
Bullish517.3%
Neutral1758.6%
Bearish724.1%
Hormel Foods Corporation · HRL · FY2026 Q1 · Calendar Q1 2026
Hormel reaffirms guidance as Foodservice and International offset Retail softness
The quarter supports a measured improvement case: organic sales growth continued and Foodservice and International were strong, but Retail softness, input costs, and logistics pressures keep the outlook dependent on execution.
Reported Before market openNYSEConsumer Defensive
$10.91B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.34
Consensus $0.32
EPS surprise
+6.3%
Reported versus consensus
Reported revenue
$3.03B
Consensus $3.07B
Revenue surprise
-1.3%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-1.9%
Event window
SPY move
-0.6%
Same window
Abnormal move
-1.4%
Stock minus SPY
Volume
1.4×
Versus trailing sessions
Subsequent drift
-7.9%
Up to 20 sessions
HRLSPY benchmark
Ask FN2 about HRL FY2026 Q1
Transcript, numbers and history already loaded
Why did HRL fall 1.9% after beating EPS estimates in FY2026 Q1?What changed in HRL's guidance and outlook in FY2026 Q1?Give me the bull and bear case for HRL after FY2026 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Hormel reported 2% organic net sales growth and adjusted diluted EPS of $0.34. It reaffirmed full-year guidance, highlighted restructuring and Transform & Modernize efforts, and announced an agreement to sell the whole-bird turkey business.
Guidance delta
Full-year guidance was reaffirmed: 1%-4% organic sales growth and adjusted EPS of $1.43-$1.51.
Key takeaways
- Organic net sales grew 2% year over year, the fifth consecutive quarter of growth.
- Foodservice and International drove momentum, while Retail sales declined 2% amid a private-label exit and cost pressures.
- Hormel announced the sale of its whole-bird turkey business and plans to focus more on value-added Jennie-O products.
Management priorities
- Continue restructuring and deliver SG&A savings.
- Invest in technology, data, e-commerce, and order-to-cash modernization.
- Advance value-added Jennie-O products and new platforms including Flash 180 chicken and Black Label bacon.
Follow HRL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$19.84Previous close
$23Low
$32.3Average
$54High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BNP Paribas | Neutral | Neutral | Maintain | Aug 28, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 14, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 9, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jun 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Dec 9, 2025 |
| Piper Sandler | Neutral | Neutral | Maintain | Dec 5, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 30, 2025 |
| Citigroup | Buy | Buy | Maintain | Nov 19, 2024 |
| Argus Research | Hold | Buy | Downgrade | Mar 30, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Mar 3, 2023 |
| Seaport Global | Neutral | Neutral | Maintain | Sep 8, 2020 |
| CFRA | Hold | Hold | Maintain | May 21, 2020 |
| Bank of America | Underperform | Underperform | Maintain | Oct 25, 2019 |
| Buckingham Research | Neutral | Neutral | Maintain | May 24, 2019 |
| Jefferies | Hold | Buy | Downgrade | Nov 27, 2018 |
| Vertical Research | Sell | Hold | Downgrade | Nov 6, 2018 |
| Vertical Group | Sell | Hold | Downgrade | Nov 6, 2018 |
| BMO Capital | Market Perform | Outperform | Downgrade | Sep 17, 2018 |
| Buckingham | Neutral | Neutral | Maintain | Aug 16, 2018 |
| Mizuho | Underperform | Neutral | Downgrade | Jul 25, 2018 |
| Morgan Stanley | Underweight | Underweight | Maintain | Nov 3, 2017 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | Dec 2, 2016 |
| Oppenheimer | Perform | Perform | Maintain | Sep 16, 2016 |
| Edward Jones | Buy | Hold | Upgrade | Sep 16, 2016 |
| BB&T Capital | Underweight | Hold | Downgrade | Apr 5, 2016 |
| CLSA | Underperform | Outperform | Downgrade | Feb 18, 2016 |
| Deutsche Bank | Hold | Hold | Maintain | Feb 17, 2016 |
| DA Davidson | Neutral | Neutral | Maintain | Nov 26, 2013 |
| Davenport | Buy | Neutral | Upgrade | Jul 1, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $19.84. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stephens | Analyst unavailable | $23 | $21.28 | +15.9% | Aug 28, 2026 |
| Coker Palmer | Thomas Palmer | $26 | $24.44 | +31.0% | Aug 14, 2026 |
| Goldman Sachs | Analyst unavailable | $25 | $20.76 | +26.0% | May 21, 2026 |
| Stephens | Analyst unavailable | $22 | $20.76 | +10.9% | May 21, 2026 |
| Stephens | Analyst unavailable | $25 | $24.3 | +26.0% | Feb 11, 2026 |
| Barclays | Analyst unavailable | $30 | $23.85 | +51.2% | Dec 9, 2025 |
| Piper Sandler | Michael Lavery | $26 | $24.16 | +31.0% | Dec 5, 2025 |
| Coker Palmer | Thomas Palmer | $28 | $24.16 | +41.1% | Dec 4, 2025 |
| Goldman Sachs | Analyst unavailable | $27 | $21.49 | +36.1% | Oct 30, 2025 |
| Barclays | Benjamin Theurer | $34 | $25.69 | +71.4% | Aug 29, 2025 |
| Goldman Sachs | Analyst unavailable | $35 | $30.85 | +76.4% | Jun 23, 2025 |
| Piper Sandler | Michael Lavery | $33 | $32.53 | +66.3% | Dec 5, 2024 |
| BNP Paribas | Max Gumport | $28 | $32.19 | +41.1% | Oct 21, 2024 |
| Bank of America Securities | Peter Galbo | $30 | $31.01 | +51.2% | Sep 4, 2024 |
| Coker Palmer | Thomas Palmer | $37 | $31.25 | +86.5% | Aug 13, 2024 |
| Coker Palmer | Thomas Palmer | $29 | $30.79 | +46.2% | May 30, 2024 |
| Coker Palmer | Thomas Palmer | $35 | $35.47 | +76.4% | May 22, 2024 |
| Argus Research | Analyst unavailable | $54 | $45.55 | +172.2% | Dec 30, 2022 |
| J.P. Morgan | Analyst unavailable | $47 | $47.04 | +136.9% | Dec 1, 2022 |
| Argus Research | Analyst unavailable | $53 | $46.83 | +167.1% | Sep 22, 2022 |
| Stephens | Analyst unavailable | $55 | $50.72 | +177.2% | Aug 23, 2022 |
| Piper Sandler | Michael Lavery | $49 | $46 | +147.0% | Dec 10, 2021 |
Track every rating change on HRL the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationHormel Foods Corporation is a prominent global food company that specializes in the creation, preparation, and supply of a diverse array of meat, nut, and other culinary items. Its extensive clientele spans retail outlets, institutional food providers (foodservice), specialty delis, and various commercial enterprises across the United States and internationally. The company's operations are strategically structured into four main divisions: Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, and International & Other. Hormel's product portfolio is broad, encompassing numerous perishable goods such as fresh meats, frozen food selections, convenient refrigerated meal options, a variety of sausages, hams, guacamole, and bacon. Additionally, it offers a wide range of non-perishable items, including canned luncheon meats, various nut butters, snack nuts, chili, microwave-ready meals, hashes, stews, tortillas, salsas, and tortilla chips.…
Historical context
All HRL earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| GIS General Mills, Inc. | FY2027 Q1 · Calendar Q3 2026 | +4.6% | +1.0% | General Mills leans on mix, innovation and e-commerce amid pressure |
| KR The Kroger Co. | FY2026 Q2 · Calendar Q3 2026 | +2.8% | +2.7% | Kroger: Strong digital growth offsets softer sales outlook |
| CPB Campbell Soup Company | FY2026 Q4 · Calendar Q3 2026 | +1.1% | -7.0% | Campbell’s leans on savings and innovation amid pressured demand |
| BF-A Brown-Forman Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | — | Brown-Forman holds FY27 outlook as RTD innovation offsets barrel pressure |
| BF-B Brown-Forman Corporation | FY2027 Q1 · Calendar Q3 2026 | 0.0% | — | Brown-Forman maintains FY27 outlook as innovation offsets pressure |
| DG Dollar General Corporation | FY2027 Q2 · Calendar Q3 2026 | +23.4% | +2.5% | Dollar General Raises FY2026 Outlook After Strong Q2 |
Latest beats and misses
Who reports nextBeat on EPS
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
Get the HRL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-25T07:20:58.287968+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-25T07:20:58.285234+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-25. For educational purposes only; not investment advice.